文献速递疝与腹壁外科急腹症与外科感染围术期管理与 ERAS

机器人补片取出术(RoME):疝修补术后慢性疼痛患者的新方法

Robotic mesh explantation (RoME): a novel approach for patients with chronic pain following hernia repair.
PubMed 文献 · Surg Endosc · 2021-11-01

本文回顾性描述29例因补片相关慢性疼痛或复发性腹壁疝行机器人补片取出术(RoME)的患者,其中19例(65.5%)有腹股沟疝修补史,10例(34.5%)有腹壁疝修补史。17例(58.6%)报告术后疼痛改善或缓解,5例(17.2%)需补片加强,术后最常见并发症为血清肿(6.8%),复发1例(3.4%)。作者认为在瘢痕、粘连及补片与周围组织融合的复杂病例中,RoME安全并为同期疝修补提供有利平台。

要点

  • 29例因补片相关慢性疼痛或复发性腹壁疝行机器人补片取出术(RoME)。
  • 17例(58.6%)术后疼痛改善或缓解,腹股沟疝修补史者63%、腹壁疝修补史者50%。
  • 术后最常见并发症为血清肿(6.8%),复发1例(3.4%),平均随访36.4天。

核心结论

  • 作者认为,对于因慢性瘢痕、粘连及补片与周围组织融合而处理困难的病例,机器人补片取出术是安全的,并为这些复杂病例的同期疝修补提供了有利平台。

研究设计与样本

  • 描述性回顾性分析,纳入2016年3月至2020年1月由两位外科医生实施的机器人补片取出术(RoME)患者,共29例,适应证为补片相关慢性疼痛或复发性腹壁疝。

主要发现

  • 29例中19例(65.5%)有腹股沟疝修补史,10例(34.5%)有腹壁疝修补史。
  • 17例(58.6%)报告术后疼痛改善或缓解,其中有腹股沟疝修补史者63%、有腹壁疝修补史者50%。
  • 5例(17.2%)在补片取出后需要补片加强,19例(65.5%)行补片取出加一期筋膜关闭或未行补片加强。
  • 平均随访36.4天,术后最常见并发症为血清肿(6.8%),报告复发1例(3.4%)。

临床怎么用

  • 作者认为,在因慢性瘢痕、粘连及补片与周围组织融合而处理困难的病例中,机器人补片取出术是安全的,并为同期疝修补提供有利平台。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-herniorrhaphy pain is common with an estimated 8-10% incidence of mesh-related complications, requiring mesh explantation in up to 6% of cases, most commonly after inguinal hernia repairs. Reoperation for mesh explantation poses a surgical challenge due to adhesions, scarring and mesh incorporation to the surrounding tissues. Robotic technology provides a versatile platform for enhanced exposure to tackle these complex cases. We aim to share our experience with a novel robotic approach to address these complex cases. METHODS: A descriptive, retrospective analysis of patients undergoing a robotic mesh explantation (RoME) for mesh-related chronic pain, or recurrent ventral hernia by two surgeons between the period of March 2016 and January of 2020. The patients were evaluated for resolution of mesh related abdominal pain as well as early post-operative complications. RoME was performed with concomitant hernia repair in cases of recurrences. RESULTS: Twenty-nine patients underwent a robotic mesh explantation (RoME) for mesh-related chronic pain, or recurrent ventral hernia between March 2016 and January of 2020. Nineteen patients (65.5%) had a prior inguinal hernia repair and 10 patients (34.5%) had a prior ventral hernia repair. Indications for mesh removal included chronic pain with or without hernia recurrence. Seventeen patients (58.6%) reported improvement or resolution of pain postoperatively (63% with a prior inguinal hernia repair and 50% of patients with a prior ventral hernia repair). Five patients (17.2%) required mesh reinforcement after explantation. Nineteen patients (65.5%) underwent mesh explantation with primary fascial closure or no mesh reinforcement. The mean follow-up was 36.4 days. The most common postoperative complication was seroma formation (6.8%), with one reported recurrence (3.4%). CONCLUSION: Robotic mesh explantation in challenging cases due to the effect of chronic scarring, adhesions and mesh incorporation to the surrounding tissues is safe and provides an advantageous platform for concomitant hernia repair in these complex cases.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Mandujano CC, Tchokouani L, Lima DL, et al. Robotic mesh explantation (RoME): a novel approach for patients with chronic pain following hernia repair. Surg Endosc. 2021. PMID: 34724577. doi:10.1007/s00464-021-08835-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。